D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$820M |
| 2 |
Visa
V
|
+$667M |
| 3 |
HES
Hess
HES
|
+$515M |
| 4 |
Mastercard
MA
|
+$425M |
| 5 |
Oracle
ORCL
|
+$382M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.03B |
| 2 |
Advanced Micro Devices
AMD
|
+$949M |
| 3 |
Citigroup
C
|
+$419M |
| 4 |
ExxonMobil
XOM
|
+$391M |
| 5 |
Booking.com
BKNG
|
+$349M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.36% |
| 2 | Consumer Discretionary | 9.47% |
| 3 | Financials | 6.95% |
| 4 | Healthcare | 6.38% |
| 5 | Communication Services | 4.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2626
Crane NXT
CXT
$2.99B
| $1.67M | ﹤0.01% |
27,059
-17,150
| -39% | -$1.01M |
|
|
NVO
2627
PUT
Novo Nordisk
NVO
$228B
| $1.67M | ﹤0.01% |
13,000
-77,000
| -86% | -$9.17M |
|
|
CVGW
2628
DELISTED
Calavo Growers
CVGW
| $1.67M | ﹤0.01% |
59,874
+18,983
| +46% | +$533K |
|
|
LKFT
2629
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.82B
| $1.66M | ﹤0.01% |
51,673
-23,967
| -32% | -$891K |
|
2630
CALL
Medifast
MED
$107M
| $1.66M | ﹤0.01% |
+43,400
| New | +$2.1M |
|
|
KREF
2631
KKR Real Estate Finance Trust
KREF
$466M
| $1.66M | ﹤0.01% |
165,196
+143,061
| +646% | +$1.57M |
|
2632
Zillow
Z
$7.78B
| $1.66M | ﹤0.01% |
34,066
-429,269
| -93% | -$23.4M |
|
2633
iShares US Regional Banks ETF
IAT
$673M
| $1.66M | ﹤0.01% |
38,296
+26,196
| +216% | +$1.07M |
|
2634
CALL
BioNTech
BNTX
$23.5B
| $1.66M | ﹤0.01% |
+18,000
| New | +$1.73M |
|
|
OPI
2635
DELISTED
Office Properties Income Trust
OPI
| $1.66M | ﹤0.01% |
813,465
+424,723
| +109% | +$1.46M |
|
2636
BlackBerry
BB
$4.58B
| $1.65M | ﹤0.01% |
600,135
+86,653
| +17% | +$253K |
|
2637
Cerence
CRNC
$359M
| $1.65M | ﹤0.01% |
104,799
+32,473
| +45% | +$549K |
|
2638
Matthews International
MATW
$887M
| $1.65M | ﹤0.01% |
53,097
+26,116
| +97% | +$808K |
|
2639
PUT
XP
XP
$8.43B
| $1.65M | ﹤0.01% |
+64,300
| New | +$1.61M |
|
2640
PUT
Teva Pharmaceuticals
TEVA
$40.4B
| $1.65M | ﹤0.01% |
116,600
-235,000
| -67% | -$2.96M |
|
2641
CALL
Signet Jewelers
SIG
$3.84B
| $1.64M | ﹤0.01% |
16,400
-10,000
| -38% | -$1,000K |
|
2642
Eaton
ETN
$141B
| $1.64M | ﹤0.01% |
5,247
-14,530
| -73% | -$3.97M |
|
2643
Jabil
JBL
$30.1B
| $1.64M | ﹤0.01% |
12,228
-9,941
| -45% | -$1.33M |
|
|
ISRL
2644
DELISTED
Israel Acquisitions Corp
ISRL
| $1.64M | ﹤0.01% |
150,000
-283,000
| -65% | -$3.04M |
|
2645
CALL
Lyft
LYFT
$5.86B
| $1.63M | ﹤0.01% |
84,400
-223,300
| -73% | -$3.42M |
|
|
NOTV
2646
DELISTED
Inotiv
NOTV
| $1.62M | ﹤0.01% |
+148,111
| New | +$885K |
|
2647
Madrigal Pharmaceuticals
MDGL
$12.6B
| $1.62M | ﹤0.01% |
6,061
-9,561
| -61% | -$2.25M |
|
2648
CALL
Badger Meter
BMI
$3.87B
| $1.62M | ﹤0.01% |
10,000
| – | – |
|
2649
Carlyle Secured Lending
CGBD
$708M
| $1.62M | ﹤0.01% |
99,316
-161,298
| -62% | -$2.53M |
|
2650
CALL
MakeMyTrip
MMYT
$5.38B
| $1.61M | ﹤0.01% |
+22,700
| New | +$1.29M |
|
Similar funds
D.E. Shaw & Co's Q1 2024 Portfolio in Review
As of Q1 2024, D.E. Shaw & Co held 4,923 positions worth $117B, up 2.1% from $114B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
D.E. Shaw & Co withdrew a net $8.58B in Q1 2024, closing 634 positions and reducing 1,722 holdings. Its most notable exit was iShares JPMorgan USD Emerging Markets Bond ETF, an estimated $307M position sold in full.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Consumer Discretionary and Financials.
Against the trend, D.E. Shaw & Co opened a new position in Arm worth $297M.
- D.E. Shaw & Co's largest Q1 2024 buy was Arm: 2,379,839 shares worth $297M.
- D.E. Shaw & Co added most to Apple in Q1 2024, an estimated $820M increase.
- D.E. Shaw & Co's biggest Q1 2024 reduction was NVIDIA, cutting an estimated $1.03B.
- D.E. Shaw & Co fully exited iShares JPMorgan USD Emerging Markets Bond ETF in Q1 2024, selling an estimated $307M.
- D.E. Shaw & Co's ten largest holdings make up 13% of its $117B portfolio in Q1 2024.
- D.E. Shaw & Co opened 655 new positions and closed 634 in Q1 2024.
- D.E. Shaw & Co's portfolio value rose 2.1% quarter-over-quarter to $117B.
Based on D.E. Shaw & Co's 13F filing for Q1 2024, filed 15 May 2024.